RELAPSE MULTIPLE MYELOMA
Clinical trials for RELAPSE MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSE MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSE MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail tested for Tough-to-Treat blood cancer
Disease control OngoingThis study is testing a combination of four existing drugs (daratumumab, clarithromycin, pomalidomide, and dexamethasone) for people with multiple myeloma whose cancer has returned or stopped responding to prior treatment. The goal is to see if this specific mix can better contro…
Matched conditions: RELAPSE MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Researchers track Real-World outcomes for patients with Hard-to-Treat blood cancer
Knowledge-focused OngoingThis observational study aims to understand how doctors in Italy currently treat patients with advanced multiple myeloma that has stopped responding to standard medications. Researchers will collect existing medical records from about 250 adult patients to analyze treatment appro…
Matched conditions: RELAPSE MULTIPLE MYELOMA
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC